Enclosed herewith disclosure under Regulation 30.

September 02, 2025 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001. Bandra (E), Mumbai - 400 051. Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir/Madam, With reference to our earlier intimation dated July 4, 2026, submitted to the Stock Exchanges pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the judicial proceedings of our General Manager – Sales & Marketing, in the matter, we wish to inform you that the matter continues to remain sub judice and is awaiting hearing and adjudication before the Hon’ble Court of Law. The Company had informed the current status of the case to Investors through its Earnings call and its Transcript submitted to Stock Exchanges on August 14, 2026, and August 18, 2026, respectively. As on date, there has been no further development or order passed by the Hon’ble Court in the matter. The Company shall continue to monitor the matter and will duly inform the Stock Exchanges of any material development, including any order passed by the Hon’ble Court, as and when received by the Company, in accordance with the applicable regulatory requirements. You are requested to kindly take the above information on record. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE